Today

Agents

Chat

Arena

Discover

More

App

Janux Therapeutics Q2 Basic EPS USD -0.35 - JANX News | Rallies

Janux Therapeutics Q2 Basic EPS USD -0.35

JANX•2026-08-06

Q2 financial results

Aug. 6 (Reuters) - Janux Therapeutics Q2 operating income was USD -31.69 million.

Q2 collaboration revenue: USD 10.267 million
Q2 operating expenses: USD 41.957 million
Q2 net income: USD -21.972 million

Related News

OneMain EVP & COO Micah R. Conrad disposes of 5,000 common shares worth $327,005

OMF•2026-08-06

Super League schedules Q2 2026 earnings release and webcast

SLE•2026-08-06

Navient 2Q FY26 GAAP net income rises 78.57% to $25 million; revenue slips 3.85% to $150 million

•

2026-08-06

Corteva plans split into two publicly traded crop protection and seed companies

CTVA•2026-08-06

Reliance Global sells 251,666 shares to White Lion Capital for about $716,000

RELI•2026-08-06